This is the authors' abstract. We don't add key points for this paper.
Fetal alcohol syndrome is a term used to describe the birth defects associated with maternal ethanol use during pregnancy. Ethanol, a rapidly biotransformed compound, is currently the only biochemical marker used to detect maternal ethanol use during pregnancy. A minor pathway of ethanol biotransformation is the nonoxidative enzymatic reaction which leads to esterification of free fatty acids with the ethyl group of ethanol. This research explored the formation of two fatty acid ethyl esters (FAEEs), palmitic acid ethyl ester (PAEE) and stearic acid ethyl ester (SAEE), in the pregnant rat and its offspring. In this acute study, pregnant (gestational day 9) Long-Evans rats were dosed 5 g/kg with ethanol (25%) p.o., and animals were sacrificed at 15, 30, 60, 120, 240, 480, and 720 min postdose. Tissues removed for PAEE and SAEE analysis included maternal blood, liver, brain, and fetal/ placental tissue. Analysis for the FAEEs was accomplished using a one-step liquid-liquid extraction. The extracts were then analyzed by gas chromatography-mass spectrometry. Maternal blood was analyzed for ethanol. The kinetic patterns for tissue PAEE and SAEE approximated that of maternal blood ethanol. All tissues reached peak FAEE concentrations between 15 and 60 min with the exception of blood PAEE. Low but significant levels of SAEE in brain and fetal/ placental tissue were observed in the absence of detectable concentrations of blood ethanol.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vallaro et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: